Biologics: current use and future applications for personalised therapy

E. Weersink (Amsterdam, Netherlands)

Source: Virtual Congress 2021 – Wheezing illnesses along the life span
Session: Wheezing illnesses along the life span
Session type: Symposium
Number: 1636

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Weersink (Amsterdam, Netherlands). Biologics: current use and future applications for personalised therapy. Virtual Congress 2021 – Wheezing illnesses along the life span

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Anti-IgE therapy: current knowledge and future perspective
Source: International Congress 2019 – The journey towards personalized medicine in asthma: where are we now?
Year: 2019

Clinical use of new and repurposed drugs: the role and contribution of the ERS collaborative projects
Source: International Congress 2017 – In the frontline of the fight against tuberculosis
Year: 2017


Therapeutic management - Current status and future developments
Source: COVID-19 Videos
Year: 2020

New and future developments of therapy for asthma in children
Source: Eur Respir Mon 2012; 56: 224-234
Year: 2012


Clinical implications and opportunities for new drug therapies
Source: Annual Congress 2008 - Deadly networks: disease-causing protein and DNA modifications
Year: 2008


At the interface: the translational science supporting the clinical use of anti-cytokine therapy
Source: International Congress 2018 – New biologics for asthma: which patients, which agents, which results, at what cost?
Year: 2018


Challenges and limitations of individualised therapy
Source: European Multidisciplinary Conference in Thoracic Oncology 2009
Year: 2009

Current and future preventive and treatment strategies in CLAD
Source: International Congress 2015 – When chronic inflammation drives fibrosis: a lesson from lung transplantation
Year: 2015



Other options of prevention - the current state and the future
Source: Annual Congress 2003 - Latent tuberculosis infection - preventive approaches
Year: 2003

Getting approval for new therapeutic medical devices versus drugs: are the differences justified?
Source: Eur Respir Rev 2016; 25: 223-226
Year: 2016


From the bedside: upcoming new clinical strategies
Source: International Congress 2016 – Scientific Year in Review 2016
Year: 2016


In the era of personalized medicine, what are the current unmet needs in asthma?
Source: International Congress 2019 – The journey towards personalized medicine in asthma: where are we now?
Year: 2019

CF clinical care and its delivery: current and future challenges
Source: International Congress 2019 – Future of cystic fibrosis care: insights from the Lancet Commission
Year: 2019


Ensuring rational introduction and responsible use of new TB tools: outcome of an ERS multisector consultation
Source: Eur Respir J 2014; 44: 1412-1417
Year: 2014


Clinical trial landscape for M/XDR-TB: current evidence and future perspectives
Source: International Congress 2019 – Recent developments and future perspectives in the diagnosis and treatment of tuberculosis
Year: 2019


Advances in targeted therapy: the clinicians point of view
Source: International Congress 2014 – Update on lung cancer biology for clinicians
Year: 2014



Rational monitoring of COPD: where do current clinical guidelines stand?
Source: Eur Respir J 2007; 29: 1078-1081
Year: 2007